Privately insured parents caring for a child with cancer have a higher likelihood of utilizing mental health (MH) care than other parents, according to a study published online in JAMA Network Open.
Apr 9, 2024
0
0
As genomics and precision medicine advances open new avenues for personalized treatments to replace the conventional one-size-fits-all model, who will actually benefit from them? Paradigm shifts in disease treatment can change ...
Apr 8, 2024
0
1
An investigational exosome-based liquid biopsy accurately detected 97% of stage 1-2 pancreatic cancers when combined with the biomarker CA 19-9, according to research presented at the American Association for Cancer Research ...
Apr 8, 2024
0
1
For patients with gastric/gastroesophageal junction (G/GEJ) adenocarcinoma, cadonilimab plus chemotherapy is associated with improved overall survival and progression-free survival, according to a study presented at the annual ...
Apr 8, 2024
0
0
A blood test appears capable of detecting early-stage pancreatic cancers with up to 97% accuracy, a new study reports.
Apr 8, 2024
0
1
Microvascular function is lower is Black men following a recent diagnosis of prostate cancer, compared to white men, according to researchers at the Medical College of Georgia. Researchers presented their work at the American ...
Apr 8, 2024
0
0
Patients who took an angiotensin-converting enzyme (ACE) inhibitor while undergoing cancer treatment with high-dose anthracycline chemotherapy did not show any difference in troponin T levels, a biomarker associated with ...
Apr 8, 2024
0
0
The PD-1/CTLA-4 bispecific antibody cadonilimab plus chemotherapy improved progression-free survival and overall survival in patients with untreated, HER2-negative, locally advanced or metastatic gastric or gastroesophageal ...
Apr 8, 2024
0
0
Clinical trials for cancer drugs have three stages, Phase I–III, before marketing, each with different evaluation items. However, there is no consensus on the appropriateness of evaluation criteria for early-stage clinical ...
Apr 8, 2024
0
0
SYNC-T, an investigational therapy that combines a device-induced vaccination at the tumor site with intratumoral infusion of a multitarget biologic drug led to numerous clinical responses in patients with metastatic castrate-resistant ...
Apr 8, 2024
0
0
